---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-016984"
form_type: "8-K"
ticker: "VXRT"
cik: "0000072444"
company_name: "Vaxart, Inc."
filed_at: "2023-06-08T23:59:59+00:00"
generated_at: "2026-06-14T05:22:57.389968+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Vaxart prices $15M public offering of 16M shares; net ~$13.6M

## Summary
- Offering of 16M shares of common stock at $0.9375 per share for gross proceeds of $15M.
- Net proceeds expected ~$13.6M (or ~$15.7M if underwriter's 30-day option fully exercised).
- Underwriter Cantor Fitzgerald granted a 30-day option to purchase up to 2.4M additional shares.
- Proceeds to be used for clinical/preclinical development, manufacturing, and general corporate purposes.
- Offering expected to close June 9, 2023, subject to customary conditions.

## SEC filing metadata
- accession: 0001437749-23-016984
- form_type: 8-K
- ticker: VXRT
- cik: 0000072444
- company_name: Vaxart, Inc.
- filed_at: 2023-06-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72444/000143774923016984/0001437749-23-016984-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72444/000143774923016984/vxrt20230608_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-016984
- JSON: https://secwatch.observer/filing/0001437749-23-016984.json
- Plain text: https://secwatch.observer/filing/0001437749-23-016984.txt

## Key facts
- Material Agreements
  Vaxart, Inc. entered into Underwriting Agreement with Cantor Fitzgerald & Co. (effective 2023-06-07).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Cantor Fitzgerald & Co.
  - Effective: 2023-06-07
  source text: On June 7, 2023, Vaxart, Inc. (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with Cantor Fitzgerald & Co. (“Cantor”) to issue and sell to Cantor 16,000,000 shares of the Company’s common stock, par value $0.0001 (the “Common Shares”) in an underwritten public offering (the “Offering”), pursuant to a Registration Statement on Form S-3 (File No. 333-270671) and the related prospectus and prospectus supplement, in each case filed with the U.S. Securities and Exchange Commission (the “SEC”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/72444/000143774923016984/0001437749-23-016984-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.